JPRN-UMIN000013583已完成未知
PTX3 in the assessment of severity and outcome of acute pancratitis - PTX3 in the assessment of severity and outcome of acute pancratitis
Saitama Medical Center, Saitama Medical University0 个研究点目标入组 50 人开始时间: 2014年3月31日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •except not patients with acute pancreatitis in Saitama Medical Center, Saitama Medical University
研究者
相似试验
进行中（未招募）
3 期
A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone LymphomaFollicular Lymphoma, Marginal Zone LymphomaJPRN-jRCT2021210065Eiji Ueda618
已完成
不适用
Investigation of clinical outcomes of patients treated with short duration dual antiplatelet therapy after implantation of biodREsorbable-polymer drug-eluting stentcoronary artery diseaseJPRN-UMIN000037321Division of Cardiology, Department of Internal Medicine, Iwate Medical University1,200
招募中
3 期
Study of Out of Specification for TisagenlecleucelPediatric/young adult patients with r/r pALL and adult patients with r/r LBCL (including diffuse large B-cell lymphoma (DLBCL) not otherwise specified, high-grade B-cell lymphoma, and DLBCL arising from follicular lymphoma) for Part 1, and r/r ALL and r/r NHL for Part 2.JPRN-jRCT1080224903ovartis Pharma. K.K.200
尚未招募
不适用
Analysis of clinical outcome in patients with tAPL compared to de novo APL in the JALSG AML/MDS/CMML clinical observation study (JALSG-CS-07/11) -JALSG CS-07/11-tAPL studyde novo and therapy-related APL (acute promyelocytic leukemia)JPRN-UMIN000044306Japan Adult Leukemia Study Group (JALSG)670
已完成
不适用
Evaluation of degree of severity in patients with ulcerative colitis by using colon capsule endoscopeJPRN-UMIN000005107Center for Diagnostic and Therapeutic Endoscopy, Keio University40